Role of selegiline in combination therapy of Parkinson's disease
Neurology
.
1996 Dec;47(6 Suppl 3):S200-9.
doi: 10.1212/wnl.47.6_suppl_3.200s.
Authors
V V Myllylä
1
,
K Sotaniemi
,
O Mäki-Ikola
,
U K Rinne
,
E H Heinonen
Affiliation
1
Department of Neurology, University of Oulu, Finland.
PMID:
8959989
DOI:
10.1212/wnl.47.6_suppl_3.200s
No abstract available
Publication types
Review
MeSH terms
Antiparkinson Agents / adverse effects*
Drug Therapy, Combination
Humans
Levodopa / therapeutic use*
Parkinson Disease / drug therapy*
Selegiline / therapeutic use*
Substances
Antiparkinson Agents
Selegiline
Levodopa